|
CA92121A
(en)
|
1904-11-07 |
1905-03-14 |
William Waid Paddock |
Pressure filter
|
|
US5118666A
(en)
|
1986-05-05 |
1992-06-02 |
The General Hospital Corporation |
Insulinotropic hormone
|
|
US5120712A
(en)
|
1986-05-05 |
1992-06-09 |
The General Hospital Corporation |
Insulinotropic hormone
|
|
ATE164852T1
(de)
|
1990-01-24 |
1998-04-15 |
Douglas I Buckley |
Glp-1-analoga verwendbar in der diabetesbehandlung
|
|
WO1993011782A1
(en)
|
1991-12-19 |
1993-06-24 |
Southwest Foundation For Biomedical Research |
Cetp inhibitor polypeptide, antibodies against the synthetic polypeptide and prophylactic and therapeutic anti-atherosclerosis treatments
|
|
IL111785A0
(en)
|
1993-12-03 |
1995-01-24 |
Ferring Bv |
Dp-iv inhibitors and pharmaceutical compositions containing them
|
|
US5705483A
(en)
|
1993-12-09 |
1998-01-06 |
Eli Lilly And Company |
Glucagon-like insulinotropic peptides, compositions and methods
|
|
US5512549A
(en)
|
1994-10-18 |
1996-04-30 |
Eli Lilly And Company |
Glucagon-like insulinotropic peptide analogs, compositions, and methods of use
|
|
DE122010000020I1
(de)
|
1996-04-25 |
2010-07-08 |
Prosidion Ltd |
Verfahren zur Senkung des Blutglukosespiegels in Säugern
|
|
TW492957B
(en)
|
1996-11-07 |
2002-07-01 |
Novartis Ag |
N-substituted 2-cyanopyrrolidnes
|
|
US6197786B1
(en)
|
1998-09-17 |
2001-03-06 |
Pfizer Inc |
4-Carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines
|
|
GT199900147A
(es)
|
1998-09-17 |
1999-09-06 |
|
1, 2, 3, 4- tetrahidroquinolinas 2-sustituidas 4-amino sustituidas.
|
|
CO5150173A1
(es)
|
1998-12-10 |
2002-04-29 |
Novartis Ag |
Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv
|
|
US6683113B2
(en)
|
1999-09-23 |
2004-01-27 |
Pharmacia Corporation |
(R)-chiral halogenated substituted N,N-Bis-benzyl aminioalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
|
|
HUP0301335A3
(en)
|
2000-04-12 |
2006-02-28 |
Novartis Ag |
Combination of organic compounds
|
|
DK1537114T3
(da)
|
2002-08-07 |
2006-11-13 |
Novartis Ag |
Organiske forbindelser som midler til behandling af aldosteronmedierede tilstande
|
|
CN100447142C
(zh)
|
2002-11-18 |
2008-12-31 |
诺瓦提斯公司 |
咪唑并[1,5a]吡啶衍生物及治疗醛固酮所介导疾病的方法
|
|
JP2007524596A
(ja)
|
2003-02-28 |
2007-08-30 |
トランスフォーム・ファーマシューティカルズ・インコーポレイテッド |
共結晶医薬組成物
|
|
JP2007530550A
(ja)
|
2004-03-26 |
2007-11-01 |
イーライ リリー アンド カンパニー |
異脂肪血症を治療するための化合物および方法
|
|
UA90269C2
(ru)
|
2004-04-02 |
2010-04-26 |
Мицубиси Танабе Фарма Корпорейшн |
Тетрагидрохинолиновые производные и способ их получения
|
|
JP5179174B2
(ja)
|
2004-05-28 |
2013-04-10 |
ノバルティス ファーマ アーゲー |
アルドステロンシンターゼ阻害剤としてのテトラヒドロ−イミダゾ［１，５−ａ］ピリジン誘導体
|
|
US7612088B2
(en)
|
2004-05-28 |
2009-11-03 |
Speedel Experimenta Ag |
Heterocyclic compounds and their use as aldosterone synthase inhibitors
|
|
CA2568164A1
(en)
|
2004-05-28 |
2005-12-15 |
Speedel Experimenta Ag |
Heterocyclic compounds and their use as aldosterone synthase inhibitors
|
|
WO2006005726A2
(en)
|
2004-07-09 |
2006-01-19 |
Speedel Experimenta Ag |
Heterocyclic compounds
|
|
TW200716636A
(en)
|
2005-05-31 |
2007-05-01 |
Speedel Experimenta Ag |
Heterocyclic spiro-compounds
|
|
TW200716634A
(en)
|
2005-05-31 |
2007-05-01 |
Speedel Experimenta Ag |
Heterocyclic spiro-compounds
|
|
TW200716105A
(en)
|
2005-05-31 |
2007-05-01 |
Speedel Experimenta Ag |
Imidazole compounds
|
|
GT200600381A
(es)
|
2005-08-25 |
2007-03-28 |
|
Compuestos organicos
|
|
TW200804378A
(en)
|
2005-12-09 |
2008-01-16 |
Speedel Experimenta Ag |
Organic compounds
|
|
US20090156875A1
(en)
|
2006-04-04 |
2009-06-18 |
Takafumi Tomioka |
Methane separation method, methane separation apparatus, and methane utilization system
|
|
TW200808812A
(en)
|
2006-04-12 |
2008-02-16 |
Speedel Experimenta Ag |
Imidazo compounds
|
|
TW200808813A
(en)
|
2006-04-12 |
2008-02-16 |
Speedel Experimenta Ag |
Imidazo compounds
|
|
EP1886695A1
(en)
|
2006-06-27 |
2008-02-13 |
Speedel Experimenta AG |
Pharmaceutical combination of an aldosterone synthase inhibitor and a glucocorticoid receptor antagonist or a cortisol synthesis inhibitor or a corticotropin releasing factor antagonist
|
|
CA2660701A1
(en)
|
2006-08-25 |
2008-03-06 |
Novartis Ag |
Fused imidazole derivatives for the treatment of disorders mediated by aldosterone synthase and/or 11-beta-hydroxylase and/or aromatase
|
|
EA200900811A1
(ru)
|
2006-12-18 |
2009-12-30 |
Новартис Аг |
Имидазолы в качестве ингибиторов альдостеронсинтазы
|
|
KR20090090395A
(ko)
|
2006-12-18 |
2009-08-25 |
노파르티스 아게 |
4-이미다졸릴-1,2,3,4-테트라히드로퀴놀린 유도체 및 알도스테론/11-베타-히드록실라제 억제제로서의 그의 용도
|
|
EP2094669A2
(en)
|
2006-12-18 |
2009-09-02 |
Novartis AG |
1-substituted imidazole derivatives and their use as aldosterone synthase inhibitors
|
|
RU2009139811A
(ru)
|
2007-03-29 |
2011-05-10 |
Новартис АГ (CH) |
Гетероциклические спиросоединения
|
|
HK1201455A1
(en)
|
2012-01-27 |
2015-09-04 |
Gilead Sciences Inc |
Combination therapies using late sodium ion channel blockers and potassium ion channel blockers
|
|
JOP20190086A1
(ar)
*
|
2016-10-21 |
2019-04-18 |
Novartis Ag |
مشتقات نافثيريدينون جديدة واستخدامها في معالجة عدم انتظام ضربات القلب
|
|
WO2019241311A1
(en)
*
|
2018-06-11 |
2019-12-19 |
Northeastern University |
Selective ligands for modulation of girk channels
|
|
KR20230022829A
(ko)
|
2020-03-03 |
2023-02-16 |
트웬티에잇-세븐, 인크. |
Rna 결합 단백질 또는 rna 변형 단백질을 표적으로 하는 화합물
|
|
WO2022074567A1
(en)
|
2020-10-06 |
2022-04-14 |
Novartis Ag |
Pharmaceutical compositions comprising naphthyridinone derivatives and their use in the treatment of arrhythmia
|